Trump and FDA Advise Against Tylenol Use in Pregnancy Amidst Expert Criticism

On Monday, President Trump made an announcement that the Food and Drug Administration (FDA) has concerns about the use of acetaminophen, the main component in Tylenol, by pregnant women. The FDA suggests there may be a connection to autism, a claim that has faced strong opposition from medical professionals.

The announcement marks a significant shift in guidance, stirring debate within the medical community. Despite pushback from experts who argue against the association between the medication and developmental disorders, the FDA stands by its precautionary advice.

In response to these developments, Ed O'Keefe provides a detailed report on the situation. Additionally, Dr. Jon LaPook addresses the outstanding questions and concerns that continue to be raised following the FDA's announcement. Their insights offer a deeper understanding of the implications and ongoing debates surrounding this issue.